Kisqali 600 MG daily dose UU 63S
Ended Awarded Last action
- Contract number
- SPE2DR26FM48C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,560
Award facts
- Contract value 100% obligated
- $24,560.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,560 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 63 units of Kisqali 600 mg daily dose medication on January 28, 2026, with completion targeted for February 19, 2026. This non-set-aside, competitively awarded contract is a child order under AmerisourceBergen's parent company Cencora, Inc., with performance to take place at the company's corporate office in Conshohocken, Pennsylvania. Kisqali is a breast cancer treatment medication, reflecting DLA's role in supplying pharmaceutical products to support military healthcare programs and the Defense Health Agency.
This delivery order is executed under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. That comprehensive IDC serves as the primary vehicle for delivering a broad portfolio of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to military treatment facilities and veteran healthcare systems globally. The delivery order structure allows DLA to procure specific pharmaceutical needs efficiently through the established prime vendor relationship with Cencora and its subsidiary AmerisourceBergen Drug Corp.
Quick answers
Who was awarded contract SPE2DR26FM48C?
SPE2DR26FM48C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FM48C worth?
The government has obligated $24,560 on SPE2DR26FM48C.
Is contract SPE2DR26FM48C an order under another contract?
Yes. SPE2DR26FM48C is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM48C competed?
The extent of competition for SPE2DR26FM48C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award